We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK's MHRA Unveils Stricter Review Policy for Drug Promotions
UK's MHRA Unveils Stricter Review Policy for Drug Promotions
November 11, 2005
The UK’s health watchdog is ratcheting up enforcement of misleading drug promotions, announcing this week that it intends to review all promotional materials for newly licensed medicines before they are disseminated.